永久心脏起器植入高节奏率治疗耐火性右心力衰竭:一个案例报告
Yanxing Fang1,2, Wenzhi Pan1,2, Daxin Zhou1,2
1Department of Cardiology, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai 200032, China.
European heart journal. Case reports
|December 12, 2025
概括
使用心脏起器增加心率 (HR) 可能有利于右侧心力衰竭 (RHF) 患者. 一个案例研究显示,在每分钟90拍节奏后,血液动力学得到改善,胀减少,这表明RHF的潜在治疗策略.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 医疗器械技术 医疗器械技术
背景情况:
- 目前针对静心性心力衰竭 (HF) 的指导方针建议低静止心率 (HR).
- 对右侧心力衰竭 (RHF) 的最佳HR还没有得到很好的定义.
- 频率管理通常涉及解决流体过载和低心脏输出问题.
研究的目的:
- 为了研究通过节奏在患有RHF的患者中增加HR的潜在好处.
- 评估心脏起器调整的HR对RHF的血液动力学参数和临床结果的影响.
主要方法:
- 一个43岁的男性病例报告,患有与desmin相关的心肌病变和RHF.
- 心脏起器植入器调整为每分钟90拍,以控制疲劳和的最佳状态.
- 右心脏导管以评估节奏后的血液动力学变化.
- 进行12个月的随访,以评估临床状态和药物需求.
主要成果:
- 心脏输出立即改善,静脉和右心房压力在节奏后减少.
- 患者在12个月的随访中实现了纽约心脏协会I级.
- 在低剂量利尿剂治疗中,持续没有胀复发.
结论:
- 通过节拍来增加HR可能会增强心脏输出并减少RHF患者的静脉拥堵,从而保持左心室功能.
- 这种方法可以为RHF管理提供治疗选择,改善生活质量并减少住院治疗.
- 需要进行进一步的研究,以确定RHF的最佳节奏策略.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Cardiomyopathy V: Interprofessional Care
313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Dysrhythmias VI: Management of Dysrhythmias
411
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
411


